Skip to main content

Advertisement

SpringerLink
Log in

Raloxifene and Vitamin K2 Combine to Improve the Femoral Neck Strength of Ovariectomized Rats

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

We evaluated the skeletal effects of two osteoporosis therapies in an ovariectomized rat model, raloxifene and vitamin K2, as well as the vitamin K2 plus raloxifene (K + Ral) combination. In two studies, 6-month-old rats were ovariectomized, except for sham-ovariectomy controls (Sham), and dosed orally with vehicle, 30 mg/kg vitamin K2, 1 mg/kg raloxifene, or the combination of K + Ral for 6 weeks following surgery. Vitamin K2 had no effect on serum estrogen, low-density lipoprotein cholesterol (LDL-C), or urinary deoxypyridinoline levels, but slightly increased osteocalcin levels compared to Ovx. Raloxifene lowered total cholesterol, LDL-C, osteocalcin, and urinary deoxypyridinoline levels to below Ovx levels, while having no effect on estrogen levels. Raloxifene, but not vitamin K2, prevented ovariectomy-induced loss of bone in the distal femoral metaphysis and proximal tibial metaphysis, as did the K + Ral combination. Raloxifene, but not vitamin K2, partially prevented, loss of vertebral bone mineral density (BMD), whereas K + Ral had BMD greater than that of Ovx. Vitamin K2 increased bone formation rate to above Ovx, whereas raloxifene and K + Ral reduced bone formation rate to Sham levels. Vitamin K2 had no effect on eroded surface compared to Ovx, while raloxifene and K + Ral reduced eroded surface to Sham levels. Groups were not different in the BMD of femoral midshaft; however vitamin K2 was observed to increase periosteal mineralizing surface of the tibial shaft to above Ovx, while raloxifene reduced periosteal mineralizing surface toward Sham levels. Femoral neck strength was not different between groups, indicating no significant beneficial effect of either raloxifene or vitamin K2 at this site. However, K + Ral had reproducibly greater femoral neck strength than Ovx or Sham. Raloxifene, but not vitamin K2, partially prevented loss of lumbar vertebra strength; but K + Ral was not different from Sham or Ovx. Therefore, raloxifene and vitamin K2 had complementary effects on bone resorption and formation activities, respectively, resulting in a reproducible, significant improvement of femoral neck strength. These rat data suggest interesting therapeutic possibilities that may require clinical verification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. A Cranney G Guyatt L Griffith G Wells P Tugwell C Rosen (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis Endocr Rev 23 570–578 Occurrence Handle10.1210/er.2001-9002 Occurrence Handle12202472

    Article  PubMed  Google Scholar 

  2. A Cranney P Tugwell G Wells G Guyatt (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology Endocr Rev 23 496–507 Occurrence Handle10.1210/er.2001-1002 Occurrence Handle12202464

    Article  PubMed  Google Scholar 

  3. M Sato TA Grese JA Dodge HU Bryant CH Turner (1999) ArticleTitleEmerging therapies for the prevention or treatment of postmenopausal osteoporosis J Med Chem 42 1–24 Occurrence Handle10.1021/jm980344o Occurrence Handle9888829

    Article  PubMed  Google Scholar 

  4. M Shiraki Y Shiraki C Aoki M Miura (2000) ArticleTitleVitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis J Bone Miner Res 15 515–521 Occurrence Handle10750566

    PubMed  Google Scholar 

  5. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Gluer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings (1999) ArticleTitleReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282 637–645

    Google Scholar 

  6. PV Hauschka JB Lian DE Cole CM Gundberg (1989) ArticleTitleOsteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone Physiol Rev 69 990–1047 Occurrence Handle2664828

    PubMed  Google Scholar 

  7. Y Akiyama K Hara M Kobayashi T Tomiuga T Nakamura (1999) ArticleTitleInhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study Jpn J Pharmacol 80 67–74 Occurrence Handle10.1254/jjp.80.67 Occurrence Handle10446758

    Article  PubMed  Google Scholar 

  8. K Hara M Kobayashi Y Akiyama (2002) ArticleTitleVitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats Bone 31 575–581 Occurrence Handle10.1016/S8756-3282(02)00874-8 Occurrence Handle12477571

    Article  PubMed  Google Scholar 

  9. J Iwamoto JK Yeh T Takeda (2003) ArticleTitleEffect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats J Bone Miner Res 18 776–783 Occurrence Handle12674339

    PubMed  Google Scholar 

  10. DB Kimmel (1996) Animal Models for in vivo experimentation in osteoporosis research R Marcus D Feldman J Kelsey (Eds) Osteoporosis Academic Press San Diego 671–690

    Google Scholar 

  11. T Mawatari H Miura H Higaki T Moro-Oka K Kurata T Murakami Y Iwamoto (2000) ArticleTitleEffect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectbmized rats J Bone Miner Res 15 1810–1817 Occurrence Handle10977000

    PubMed  Google Scholar 

  12. M Sato J Kim LL Short CW Slemenda HU Bryant (1995) ArticleTitleLongitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats J Pharmacol Exp Ther 272 1252–1259 Occurrence Handle7891341

    PubMed  Google Scholar 

  13. M Sato C McClintock J Kim CH Turner HU Bryant D Magee CW Slemenda (1994) ArticleTitleDual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats J Bone Miner Res 9 715–724 Occurrence Handle8053401

    PubMed  Google Scholar 

  14. M Sato MK Rippy HU Bryant (1996) ArticleTitleRaloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats FASEB J 10 905–912 Occurrence Handle8666168

    PubMed  Google Scholar 

  15. RG Erben (1997) ArticleTitleEmbedding of bone samples in methymethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry J Histochem Cytochem 45 307–313 Occurrence Handle9016319

    PubMed  Google Scholar 

  16. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker (1987) ArticleTitleBone histomorphometry: standardization of nomenclature, symbols, and units Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2 595–610

    Google Scholar 

  17. CH Turner DB Burr (1993) ArticleTitleBasic biomechanical measurements of bone: a tutorial Bone 14 595–608 Occurrence Handle10.1016/8756-3282(93)90081-K Occurrence Handle8274302

    Article  PubMed  Google Scholar 

  18. RT Turner GL Evans GK Wakley (1994) ArticleTitleReduced chondroclust differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134 461–466 Occurrence Handle10.1210/en.134.1.461 Occurrence Handle7506213

    Article  PubMed  Google Scholar 

  19. N Binkley D Krueger J Engelke T Crenshaw J Suttie (2002) ArticleTitleVitamin K supplementation does not affect ovariectomy-induced bone loss in rats Bone 30 897–900 Occurrence Handle10.1016/S8756-3282(02)00734-2 Occurrence Handle12052460

    Article  PubMed  Google Scholar 

  20. CH Turner M Sato HU Bryant (1994) ArticleTitleRaloxifene preserves bone strength and bone mass in ovariectomized rats Endocrinology 135 2001–2005 Occurrence Handle10.1210/en.135.5.2001 Occurrence Handle7956922

    Article  PubMed  Google Scholar 

  21. M Sato HU Bryant P Iversen J Helterbrand F Smietana K Bemis R Higgs CH Turner I Owan Y Takano DB Burr (1996) ArticleTitleAdvantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats J Pharmacol Exp Ther 279 298–305 Occurrence Handle8859007

    PubMed  Google Scholar 

  22. A Cranney P Tugwell J Adachi B Weaver N Zytaruk A Papaioannou V Robinson B Shea G Wells G Guyatt (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23 517–523

    Google Scholar 

  23. A Cranney P Tugwell N Zytaruk V Robinson B Weaver J Adachi G Wells B Shea G Guyatt (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 23 524–528

    Google Scholar 

  24. A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23 508–516

    Google Scholar 

  25. Y Nagasawa M Fujii Y Kajimoto E Imai M Hori (1998) ArticleTitleVitamin K and serum cholesterol in patients on continuous ambulatory peritoneal dialysis Lancet 351 724 Occurrence Handle10.1016/S0140-6736(05)78492-0 Occurrence Handle9504520

    Article  PubMed  Google Scholar 

  26. T Ohyashiki Y Yabunaka K Matsui (1991) ArticleTitleAntioxidant effect of vitamin K homologues on ascorbic acid/Fe(2+)-induced lipid peroxidation of lecithin liposomes Chem Pharm Bull 39 976–979 Occurrence Handle1654222

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Sports Medicine, Keio University School of Medicine, Tokyo, Japan

    J. Iwamoto & T. Takeda

  2. Metabolism Laboratory, Department of Medicine , Winthrop-University Hospital, NY, USA

    J. K. Yeh

  3. Lilly Research Laboratories, Indianapolis, IN, USA

    A. Schmidt, E. Rowley, L. Stanfield & M. Sato

Authors
  1. J. Iwamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. K. Yeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Rowley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Stanfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Sato.

Additional information

This work was supported by Lilly Research Laboratories.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwamoto, J., Yeh, J.K., Schmidt, A. et al. Raloxifene and Vitamin K2 Combine to Improve the Femoral Neck Strength of Ovariectomized Rats. Calcif Tissue Int 77, 119–126 (2005). https://doi.org/10.1007/s00223-004-0277-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-004-0277-8

Keywords

Search

Navigation